Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S Common Stock
(NY:
NVO
)
45.68
-0.83 (-1.78%)
Official Closing Price
Updated: 7:00 PM EST, Nov 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,954,030
Open
46.04
Bid (Size)
45.90 (1,900)
Ask (Size)
45.94 (400)
Prev. Close
46.51
Today's Range
45.15 - 46.27
52wk Range
45.05 - 112.52
Shares Outstanding
N/A
Dividend Yield
4.81%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Deal Dispatch: From A Founder Comeback To Billion-Dollar Bids, This Week In M&A And Bankruptcy
Today 16:22 EST
Via
Benzinga
Why Novo Nordisk Stock Is Sinking This Week
Today 14:10 EST
The global drugmaker is facing some headwinds related to tough competition.
Via
The Motley Fool
Topics
Government
World Trade
Performance
YTD
-47.8%
-47.8%
1 Month
-22.6%
-22.6%
3 Month
-6.3%
-6.3%
6 Month
-29.6%
-29.6%
1 Year
-56.6%
-56.6%
More News
Read More
Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment
Today 12:33 EST
Via
Benzinga
FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included
Today 9:54 EST
Via
Benzinga
Trump Announces Deals With Eli Lilly, Novo Nordisk To Lower Obesity Drug Prices
November 06, 2025
Via
Stocktwits
Topics
Government
Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years?
November 06, 2025
Via
Stocktwits
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Today 8:00 EST
Via
Investor's Business Daily
Topics
Government
Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced
November 06, 2025
Via
Stocktwits
Topics
Government
World Trade
Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts
November 06, 2025
Via
Benzinga
Topics
Government
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
November 06, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Climate Change
Intellectual Property
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx
November 06, 2025
Via
Benzinga
Topics
Government
Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.
November 06, 2025
Via
The Motley Fool
Topics
Earnings
Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo
November 06, 2025
Via
Investor's Business Daily
Topics
Government
Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits
November 06, 2025
Via
Benzinga
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal
November 06, 2025
Via
Benzinga
Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further
November 06, 2025
Via
Stocktwits
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
November 06, 2025
Via
Investor's Business Daily
Novo Nordisk A/S-Spons ADR (NYSE:NVO) Embodies Affordable Growth Strategy
November 06, 2025
Via
Chartmill
Trump Administration's Weight-Loss Drug Deal Is Sending This Novo Nordisk Rival Surging: Momentum Score Spikes
November 06, 2025
Via
Benzinga
Topics
Government
Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal
November 05, 2025
Via
Stocktwits
Topics
Law Enforcement
Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars
November 05, 2025
Via
MarketMinute
Topics
Economy
Novo Nordisk Q3 2025 Earnings Call Transcript
November 05, 2025
Via
Benzinga
Topics
Earnings
Market Movers: Eli Lilly, Cadre, BP, Kellanova, and Teva Soar to 52-Week Highs Amidst Shifting Economic Tides
November 05, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Supply Chain
Druckenmiller's Viking Trade Just Hit A Golden Cross — And A Sweet 36% Gain
November 05, 2025
Via
Benzinga
Prediction: Novo Nordisk Will Soar by 2026
November 05, 2025
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 45.68
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 11/07/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.